Apoptosis by Par-4 in cancer and neurodegenerative diseases.
about
AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cellsMechanisms of apoptosis by the tumor suppressor Par-4PI3K-mediated PDGFRα signaling regulates survival and proliferation in skeletal development through p53-dependent intracellular pathwaysExpression and regulation of prostate apoptosis response-4 (Par-4) in human glioma stem cells in drug-induced apoptosisRegulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cellsProstate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cellsAutomated yeast two-hybrid screening for nuclear receptor-interacting proteins.Human PRKC apoptosis WT1 regulator is a novel PITX2-interacting protein that regulates PITX2 transcriptional activity in ocular cells.Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depressionThe Rubella virus capsid is an anti-apoptotic protein that attenuates the pore-forming ability of Bax.Tumour-suppression activity of the proapoptotic regulator Par4.Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD)Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation.Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activationMultimolecular complex of Par-4 and E2F1 binding to Smac promoter contributes to glutamate-induced apoptosis in human- bone mesenchymal stem cells.Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosisSimultaneous dual targeting of Par-4 and G6PD: a promising new approach in cancer therapy? Quintessence of a literature review on survival requirements of tumor cells.Rubella virus capsid protein: a small protein with big functions.PAR-4 as a possible new target for pancreatic cancer therapy.Cancer-selective apoptotic effects of extracellular and intracellular Par-4.Par-4 as a potential target for cancer therapy.A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survivalSystemic Par-4 inhibits non-autochthonous tumor growth.A complex regulatory network of transcription factors critical for ocular development and disease.Exacerbation of apoptosis of cortical neurons following traumatic brain injury in par-4 transgenic mice.Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cellsPar-4 is an essential downstream target of DAP-like kinase (Dlk) in Dlk/Par-4-mediated apoptosis.The pro-apoptotic protein Par-4 facilitates vascular contractility by cytoskeletal targeting of ZIPK.Recombinant Production and Characterization of SAC, the Core Domain of Par-4, by SUMO Fusion System.Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats.Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition.A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.TNF-α and IFN-γ Together Up-Regulates Par-4 Expression and Induce Apoptosis in Human Neuroblastomas.Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis.
P2860
Q24300117-9D7B8E2B-DD6C-4625-BF29-CFED1FDFF992Q24679137-BFB1BE2A-A927-4FD6-8C8F-E8380337188BQ27011309-1D08C1FD-E27E-40D0-AA0D-60C49BE9BE8FQ28512064-8810E790-5EF9-41A0-9204-4D9F42A78C00Q28539708-6EB6D1AF-124C-4FDD-958E-DC7D5F707B43Q28575412-DF8320DB-2609-4F45-9303-F0AF27A56297Q30437841-85246901-63C4-4650-88D7-CC8A0C9D5333Q33209988-69BC5170-6E29-491D-A878-BBD0ECD2E7D1Q33508415-072A74BA-05BF-4B99-AAA6-81556CDECFE9Q33798728-D90CC5D5-F91D-450A-A856-D7002C5726D7Q33838271-1FF0465B-14C6-48E7-AA2C-D0D1EBB96337Q34360323-DE952427-4B31-4FF9-BC57-03756C851F14Q35545259-504538BE-9F25-4B38-9458-0A4101652FF6Q35739198-966DE4CA-5F36-4C12-AF5F-EF0CBB297EA8Q35955278-63147426-9F22-48B2-B5D6-F58E61EABDB2Q36859241-4F1F9010-B5F7-4F71-AD51-6CEF747B2079Q37154187-3E9B65E7-C316-48D5-A528-5848BA419AE0Q37417255-57529CBC-5539-441D-84AE-2F9CC2C912D2Q37721412-6C8F23A0-B3F9-4608-9E14-6EAC394A1A1FQ37738894-84C1E015-3ABC-40C4-A98F-9C227DD9F717Q37741771-46CAEE83-5120-43C6-9D8C-2120C40F1D99Q38051738-B90AEB3A-9908-4DE5-A404-87EF2A985A12Q38559343-4064E45B-8666-4973-A4C8-FD53AB3ED0E8Q38875552-9CAD0D59-3D6E-4FB4-9401-B8A406972A4CQ38895762-3244BD22-1E8B-428C-B62F-5B440F965E54Q38978316-0769FE8C-95B2-4D23-B3FE-77F1CE1B78ABQ39536273-AF6E555C-79C0-47ED-AD6A-3F220E44576DQ39600052-33D825D1-08B8-46C8-853C-E3A20D4EB8D6Q40795389-0D7203CC-571F-4AB5-B322-157A8A9C2571Q40891090-6EEBE741-BC5D-45AB-A66F-02B6F1BEC2B4Q41202282-0415AF50-39D5-47A9-976E-8F1D8D6C21E1Q42554900-823F45A6-CC56-4902-AAA3-4355BB5E1B92Q42974594-B3EB4902-E706-4020-88B2-942C20B299A9Q47608040-4FD5300C-0BEF-4FB8-B0E3-B790BBDBA94EQ48166027-3016C47D-DBF5-4C3C-9EE9-8B290E86D9F2Q48247781-1EBF2DBF-1073-4C70-867C-BB08730D5F2DQ50059072-1F1D9567-16DB-4D3D-829A-2ABDFDF8D42FQ50938497-58927AA1-C657-4620-AD86-5697BFA7285AQ52738313-8FF5EC6A-6706-43E1-9BD7-BF636724165EQ53301550-5F375E99-BE85-4461-B6BA-608451989DEE
P2860
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@ast
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@en
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@nl
type
label
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@ast
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@en
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@nl
prefLabel
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@ast
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@en
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@nl
P1476
Apoptosis by Par-4 in cancer and neurodegenerative diseases.
@en
P2093
Nadia El-Guendy
Vivek M Rangnekar
P356
10.1016/S0014-4827(02)00016-2
P407
P577
2003-02-01T00:00:00Z